Zydus gets USFDA approval for generic drug to treat multiple sclerosis

Q: How long will it take to read this news story?

The story "Zydus gets USFDA approval for generic drug to treat multiple sclerosis" has 221 words across 9 sentences, which will take approximately 1 - 2 minutes for the average person to read.

Q: Which news outlet covered this story?

The story "Zydus gets USFDA approval for generic drug to treat multiple sclerosis" was covered 18 hours ago by Business Standard, a news publisher based in India.

Q: How trustworthy is 'Business Standard' news outlet?

Business Standard is a fully independent (privately-owned) news outlet established in 1975 that covers mostly business and finance news. The outlet is headquartered in India and publishes an average of 284 news stories per day. It's most recent story was published 4 hours ago.

Q: What do people currently think of this news story?

The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.

Q: How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.<ul><li>News ID: #28507245</li><li>URL: https://apeiron.beamstart.com/news/zydus-gets-usfda-approval-for-17467701878738</li></ul>

Business Standard Logo Business Standard 18h ago

Zydus gets USFDA approval for generic drug to treat multiple sclerosis - Business Standard

Quick Summary:

"This approval underscores Zydus' leadership in bringing complex, differentiated generics to market, reinforcing our commitment to providing a comprehensive range of therapeutic choices for patients," Zydus Lifesciences MD Sharvil Patel said.

Zydus Lifesciences on Friday said it has received approval from the US health regulator to market a generic medication to treat multiple sclerosis.

The company has received approval from the US Food and Drug Administration (USFDA) for Glatiramer Acetate Injection, 20 mg/mL and 40 mg/mL, single-dose prefilled syringes.